자궁경부암 진단
문의하기
| 기술분야 | 보건/의료 |
|---|---|
| 개발상태 | Already on the market |
| 보유기관 | |
| 기술유형 | |
| 지식재산권 | Secret know-how |
| 보유국가 | 독일 |
- 제품소개
- Summary암세포의 특징인 후성유전학적 변화(DNA 메틸화)에 기초한 빠르고 신뢰할 수 있는 진단테스트입니다. 전 세계적으로 여성에게 세 번째로 흔한 자궁경부암 타겟으로 합니다. 조산의 원인인 불필요한 수술 방지하는 목적이며, 안정적이고 강력한 DNA 세포 조절 메커니즘을 감지합니다.DescriptionA young German SME specialized in molecular biology and cancer diagnostics has developed a fast and reliable diagnostic test based on epigenetic changes (DNA methylation) which are characteristic for cancer cells. These highly informative biomarkers validated in clinical trials and applicable for early detection of cervical cancer. Corresponding marker sets for head-and-neck tumor and ovarian cancer are also validated. Seeking medical partners for licensing and technical cooperation agreements.Technology Keywords06001003 - Cytology, Cancerology, Oncology06002007 - In vitro Testing, Trials06001005 - Diagnostics, Diagnosis06002002 - Cellular and Molecular BiologMarket Application Keywords05001001 - Diagnostic services05001002 - In-vitro diagnostics05005006 - Gynaecology05001005 - Molecular diagnosis05004005 - Diagnostic equipmentSector GroupHealthType and Role of Partner SoughtPartners sought for license and technical cooperation agreements: The company is looking for exclusive diagnostic providers in the cancer area especially in the US and Europe with corresponding technical background and capabilities for market promotion.Type of Partnership ConsideredCommercial agreement with technical assistance